Literature DB >> 10632551

Selective arterial embolization in the management of symptomatic renal angiomyolipomas.

D Mourikis1, A Chatziioannou, A Antoniou, D Kehagias, D Gikas, L Vlahos.   

Abstract

Current management of renal angiomyolipomas (AMLs) include observation, transcatheter embolization and partial or total nephrectomy. Patients symptoms and size of the lesion are the determinants for the choice of the treatment. In general symptomatic or greater than 8 cm masses require intervention. A retrospective study of five patients presented with symptomatic lesions and treated with selective transcatheter embolization, over a 3 year period was performed in our hospital. A total of eight embolizations were performed, all on an emergency basis due to retroperitoneal bleeding or significant hematuria. Surgical intervention was necessary in one case, due to massive rebleeding on the fourth post-procedural day. Two patients rebled within 6 months and 2 years respectively, and were managed successfully with additional embolization. The remaining two patients are still asymptomatic 26 and 18 months after the successful initial result. Experience with this procedure is reported on with emphasis to the clinical outcome. It is believed that selective arterial embolization should be the standard initial therapy for symptomatic renal AMLs.

Entities:  

Mesh:

Year:  1999        PMID: 10632551     DOI: 10.1016/s0720-048x(98)00179-x

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  7 in total

1.  Management of renal abscess formation after embolization due to renal angiomyolipomas in two cases.

Authors:  Hamdi Ozkara; Burak Ozkan; Vural Solok
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

Review 2.  Optimal treatment of tuberous sclerosis complex associated renal angiomyolipomata: a systematic review.

Authors:  John J Bissler; John C Kingswood
Journal:  Ther Adv Urol       Date:  2016-04-06

3.  Radiofrequency ablation for tumor-related massive hematuria.

Authors:  Ziv Neeman; Shawn Sarin; Jonathan Coleman; Tito Fojo; Bradford J Wood
Journal:  J Vasc Interv Radiol       Date:  2005-03       Impact factor: 3.464

4.  Patterns of renal angiomyolipoma regression post embolisation on medium- to long-term follow-up.

Authors:  K Patatas; G J Robinson; D F Ettles; R Lakshminarayan
Journal:  Br J Radiol       Date:  2013-02-07       Impact factor: 3.039

5.  Embolization of spontaneous intratumoral hemorrhage with the hemodynamic characteristics of arteriovenous fistula in renal angiomyolipoma.

Authors:  Nao Kikuchi; Ryohei Kuwatsuru; Shinsuke Kyogoku; Akihiko Shiraishi; Shingo Okada; Daisuke Tsuge; Yuki Yamashiro
Journal:  Case Rep Nephrol Dial       Date:  2015-01-27

6.  Treatment of renal angiomyolipoma: pooled analysis of individual patient data.

Authors:  Teele Kuusk; Fausto Biancari; Brian Lane; Conrad Tobert; Steven Campbell; Uri Rimon; Vito D'Andrea; Aare Mehik; Markku H Vaarala
Journal:  BMC Urol       Date:  2015-12-28       Impact factor: 2.264

7.  Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference.

Authors:  Darcy A Krueger; Hope Northrup
Journal:  Pediatr Neurol       Date:  2013-10       Impact factor: 3.372

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.